Time to prove a treatment-related prostate cancer survival benefit

For most of the past 20 years it has generally been considered that it took 10 years to show that a new form of therapy was effective and safe in the treatment of localized prostate cancer. We may need to seriously re-assess that time period. … READ MORE …

“Best care” doesn’t equate to better outcomes! That’s not good!

A poster by Schroeck et al. — to be presented on May 20 at the upcoming annual meeting of the American Urological Association (AUA) — presents the latest set of data suggesting that “best care” does not lead to appropriate outcomes quality for men receiving standard forms of treatment for localized prostate cancer. … READ MORE …

Increasing transparency about quality of sexual function after surgery

A recent study in the Journal of Endourology reports prospective data on the recovery of potency following radical prostatectomy and concludes that the “overwhelming majority of men experience a deterioration in the overall quality of erection” after robot-assisted prostatectomy. … READ MORE …

Gee … on-line support systems for prostate cancer patients actually work!

In the management of patients being treated for prostate cancer, “Providing support using online methods is effective; the length of time this intervention should be provided to patients will require further research.” … READ MORE …

Of cost, quality, and care for low-risk prostate cancer

A newly published study in the Annals of Internal Medicine has offered an analysis of the cost-effectiveness of “observation” as compared to immediate initial treatment for men diagnosed with low-risk, localized prostate cancer. … READ MORE …

“Raising the bar” for outcomes after radical prostatectomy

There is another rather entertaining, 10-minute video today on the Medscape Oncology web site showing a conversation  between Dr. Matt Cooperberg of the University of California, San Francisco and Dr. Andrew Vickers of the Memorial Sloan-Kettering Cancer Center in New York. … READ MORE …

Men in minorities or treated under Medicaid receive lower quality care

In yet another utterly unsurprising “research” finding, a new article in the Journal of Urology has shown that — in the USA — minority prostate cancer patients and prostate cancer patients treated under Medicaid are less likely to have their prostates removed at high-experience and high-volume hospitals where there is high use of robot-assisted surgical techniques. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,144 other followers